Sedana Medical receives approval for AnaConDa in Japan
Sedana Medical AB (publ) (Sedana Medical or the company) announces today that the company has received market approval for AnaConDa from the Ministry of Health, Labour and Welfare (MHLW) in Japan. Through the approval, AnaConDa can now be marketed, sold and used in intensive care for the administration of volatile anaesthetics for mechanically ventilated patients. Sedana Medical and their Japanese distributor, who will promote the product, are now preparing for market launch in Japan during 2019.AnaConDa is Sedana Medical’s product for administration of volatile anaesthetics for